Suri, G., Chandiwana, D., Lee, A., & Mistry, R. (2019). Cost-effectiveness analysis of ribociclib plus letrozole versus palbociclib plus letrozole in the United Kingdom. J Health Econ Outcomes Res.
Citação norma ChicagoSuri, Gaurav, David Chandiwana, Adam Lee, and Rohit Mistry. "Cost-effectiveness Analysis of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole in the United Kingdom." J Health Econ Outcomes Res 2019.
Citação norma MLASuri, Gaurav, David Chandiwana, Adam Lee, and Rohit Mistry. "Cost-effectiveness Analysis of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole in the United Kingdom." J Health Econ Outcomes Res 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.